FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to methods of treating inflammatory intestinal diseases, and includes a glucocorticosteroid therapy, wherein additionally low-molecular heparins 9500 IU/ml are used by 0.3–0.8 ml per day for 7–14 days.
EFFECT: invention provides higher clinical effectiveness in IID.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SURGICAL TREATMENT OF PATIENTS WITH A STRUCTURING FORM OF CROHN'S DISEASE | 2023 |
|
RU2806298C1 |
METHOD FOR ASSESSING CLINICAL EFFECTIVENESS IN IRRITABLE BOWEL SYNDROME ACCOMPANIED BY DIARRHOEA | 2014 |
|
RU2570767C1 |
METHOD OF LACTASE DEFICIENCY IN ADULTS TREATMENT | 2017 |
|
RU2684099C1 |
METHOD FOR PREVENTING TUBERCULOSIS IN INFLAMMATORY INTESTINAL DISEASES | 2018 |
|
RU2712943C1 |
METHOD OF TREATING CYTOMEGALOVIRUS INFECTION | 2013 |
|
RU2540474C2 |
METHOD OF DIAGNOSING THE SEVERITY OF IRRITABLE BOWEL SYNDROME | 2017 |
|
RU2668496C2 |
METHOD FOR DIAGNOSING SEVERE PSEUDOMEMBRANOUS COLITIS IN PATIENTS AFTER CORONAVIRUS INFECTION | 2022 |
|
RU2786752C1 |
METHOD FOR TREATING CHRONIC RADIATION PROCTITIS | 2020 |
|
RU2763985C1 |
METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES | 2009 |
|
RU2394571C1 |
METHOD OF THE TREATMENT OF POLYNEUROPATHY ASSOCIATED WITH GLUTEN-SENSITIVE CELIAC DISEASE | 2022 |
|
RU2800847C1 |
Authors
Dates
2019-06-07—Published
2018-08-03—Filed